A phase II study of cabozantinib and temozolomide in patients with unresectable or metastatic leiomyosarcoma and other soft tissue sarcomas

被引：0
|
作者：
Agulnik, Mark
Okuno, Scott H.
Van Tine, Brian Andrew
Pollack, Seth
Weiss, Mia C.
Hirbe, Angela C.
Viveiros, Pedro
Schulte, Brian
Frankel, Paul Henry
Attia, Steven
Siontis, Brittany L.
Milhem, Mohammed M.
Monga, Varun
Charlson, John A.
Robinson, Steven Ian
Yoon, Janet
机构：
[1] City Hope Comprehens Canc Ctr, Durarte, CA USA
[2] Mayo Clin, Rochester, MN USA
[3] Washington Univ St Louis, St Louis, MO USA
[4] Northwestern Univ, Chicago, IL USA
[5] Washington Univ, Sch Med, St Louis, MO USA
[6] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[7] Mayo Clin, Jacksonville, FL USA
[8] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA USA
[9] Univ Iowa, Iowa City, IA USA
[10] Med Coll Wisconsin, Milwaukee, WI USA
[11] City Hope Natl Med Ctr, Duarte, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11505
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Systematic Therapy for Unresectable or Metastatic Soft-Tissue Sarcomas: Past, Present, and Future
    Sherif S. Morgan
    Lee D. Cranmer
    Current Oncology Reports, 2011, 13 : 331 - 349
  • [32] Systematic Therapy for Unresectable or Metastatic Soft-Tissue Sarcomas: Past, Present, and Future
    Morgan, Sherif S.
    Cranmer, Lee D.
    CURRENT ONCOLOGY REPORTS, 2011, 13 (04) : 331 - 349
  • [33] Continuous daily dosing (CDD) of sunitinib (SU) in patients with metastatic soft tissue sarcomas (STS) other than GIST: Results of a phase II trial
    Keohan, M. L.
    Morgan, J. A.
    D'Adamo, D. R.
    Harmon, D.
    Butrynski, J. E.
    Wagner, A. J.
    Schwartz, G. K.
    Maki, R. G.
    Demetri, G. D.
    George, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas
    Hartmann, JT
    Oechsle, K
    Mayer, F
    Kanz, L
    Bokemeyer, C
    ANTICANCER RESEARCH, 2003, 23 (2C) : 1899 - 1901
  • [35] Phase II trial of gemcitabine in patients with pretreated advanced soft tissue sarcomas
    Späth-Schwalbe, E
    Genvresse, I
    Koschuth, A
    Dietzmann, A
    Grunewald, R
    Possinger, K
    ANTI-CANCER DRUGS, 2000, 11 (05) : 325 - 329
  • [36] Treatment of unresectable or metastatic pediatric soft tissue sarcomas with surgery, irradiation, and chemotherapy: A pediatric oncology group study
    Pratt, CB
    Maurer, HM
    Gieser, P
    Salzberg, A
    Rao, BN
    Parham, D
    Thomas, PRM
    Marcus, RB
    Cantor, A
    Pick, T
    Green, D
    Neff, J
    Jenkins, JJ
    MEDICAL AND PEDIATRIC ONCOLOGY, 1998, 30 (04): : 201 - 209
  • [37] PHASE II STUDY OF NEOADJUVANT BEVACIZUMAB AND RADIOTHERAPY FOR RESECTABLE SOFT TISSUE SARCOMAS
    Yoon, Sam S.
    Duda, Dan G.
    Karl, Daniel L.
    Kim, Tae-Min
    Kambadakone, Avinash R.
    Chen, Yen-Lin
    Rothrock, Courtney
    Rosenberg, Andrew E.
    Nielsen, G. Petur
    Kirsch, David G.
    Choy, Edwin
    Harmon, David C.
    Hornicek, Francis J.
    Dreyfuss, Jonathan
    Ancukiewicz, Marek
    Sahani, Dushyant V.
    Park, Peter J.
    Jain, Rakesh K.
    DeLaney, Thomas F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (04): : 1081 - 1090
  • [38] Safety and Efficacy of Anlotinib-based Regimen in Patients with Unresectable or Metastatic Bone and Soft-tissue Sarcomas: A Retrospective Institutional Study
    Pang, Lina
    Zhang, Shengli
    Wang, Liye
    Gong, Shuai
    He, Wei
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2025,
  • [39] PHASE II STUDY OF IPILIMUMAB PLUS TEMOZOLOMIDE IN PATIENTS WITH METASTATIC MELANOMA
    Patel, S.
    Bassett, R.
    Hwu, W.
    Kim, K.
    Papadopoulos, N.
    Hwu, P.
    Bedikian, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 366 - 367
  • [40] Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates
    Haddox, Candace L.
    Nathenson, Michael J.
    Mazzola, Emanuele
    Lin, Jia-Ren
    Baginska, Joanna
    Nau, Allison
    Weirather, Jason L.
    Choy, Edwin
    Marino-Enriquez, Adrian
    Morgan, Jeffrey A.
    Cote, Gregory M.
    Merriam, Priscilla
    Wagner, Andrew J.
    Sorger, Peter K.
    Santagata, Sandro
    George, Suzanne
    CLINICAL CANCER RESEARCH, 2024, 30 (07) : 1281 - 1292
12345